Biosimilars: A new scenario in biologic therapies.

@article{LpezMatencio2017BiosimilarsAN,
  title={Biosimilars: A new scenario in biologic therapies.},
  author={Jos{\'e} M Serra L{\'o}pez-Matencio and Alberto Morell Baladr{\'o}n and Santos Casta{\~n}eda},
  journal={Reumatologia clinica},
  year={2017},
  volume={13 5},
  pages={287-293}
}
There is no doubt that biologic therapies provide added value for health systems. However, due to their special nature, they also raise some questions that make highly rigorous and demanding quality control and monitoring of their use indispensable. This circumstance is reinforced with the appearance on the scene of biosimilars, which, given their lower… CONTINUE READING